Skip to main navigation Skip to search Skip to main content

Heparin and anticoagulation

  • Akihiro Onishi
  • , Kalib St Ange
  • , Jonathan S. Dordick
  • , Robert J. Linhardt

Research output: Contribution to journalArticlepeer-review

220 Scopus citations

Abstract

Heparin, a sulfated polysaccharide, has been used as a clinical anticoagulant for over 90 years. Newer anticoagulants, introduced for certain specialized applications, have not significantly displaced heparin and newer heparin-based anticoagulants in most medical procedures. This chapter, while reviewing anticoagulation and these newer anticoagulants, focuses on heparin-based anticoagulants, including unfractionated heparin, low molecular weight heparins and ultra-low molecular weight heparins. Heparin's structures and its biological and therapeutic roles are discussed. Particular emphasis is placed on heparin's therapeutic application and its adverse effects. The future prospects are excellent for new heparins and new heparin-based therapeutics with improved properties.

Original languageEnglish
Pages (from-to)1372-1392
Number of pages21
JournalFrontiers in Bioscience - Landmark
Volume21
Issue number7
DOIs
StatePublished - 1 Jun 2016
Externally publishedYes

Keywords

  • Anticoagulants
  • Anticoagulation
  • Bioengineered heparin
  • Bovine heparin
  • Heparin
  • Review

Fingerprint

Dive into the research topics of 'Heparin and anticoagulation'. Together they form a unique fingerprint.

Cite this